Plumbline Life Sciences, Inc. (XKON:222670)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,500.00
-170.00 (-3.64%)
At close: Feb 2, 2026
7.27%
Market Cap18.15B +49.9%
Revenue (ttm)n/a
Net Income-773.99M
EPS-771.00
Shares Out4.03M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,548
Average Volume2,191
Open4,690.00
Previous Close4,670.00
Day's Range4,500.00 - 4,690.00
52-Week Range3,645.00 - 8,560.00
Beta0.34
RSI32.64
Earnings Daten/a

About Plumbline Life Sciences

Plumbline Life Sciences, Inc. engages in the development and sale of DNA medicines for animals. Its products include LifeTide SW5, a pig immune-modulator; PLS-ASF, a swine fever DNA vaccine; PLS-FMD; PLS-B3000, a dairy cattle DNA therapy; PLS-IF1000, a FMD vaccine; PLS-H1000, a horse laminitis therapy; PLS-D5000, a dog DNA cancer immunotherapy; PLS-D1000 for age related immune deficiency in senior dogs; and PLS-C2000 for age related immune deficiency in senior cats. Plumbline Life Sciences, Inc. was founded in 2014 and is headquartered in Seoul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 222670
Full Company Profile